PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zhu, HX; Wang, HX; Cheng, Y; Liu, DY; Zhang, AZ; Wen, ZZ; Gao, JA				Zhu, Haixia; Wang, Hongxiang; Cheng, Yin; Liu, Dongyue; Zhang, Aizhen; Wen, Zongzhuang; Gao, Jiangang			Hadh deficiency induced oligoasthenoteratozoospermia through the TNF-alpha/Bcl-2 pathway in male mice	FASEB JOURNAL			English	Article						apoptosis; etanercept; Hadh; multinucleated giant germ cells; testicular inflammation	NECROSIS-FACTOR-ALPHA; MULTINUCLEATED SPERMATOCYTES; MALE-INFERTILITY; FATTY-ACIDS; INFLAMMATION; EXPRESSION; APOPTOSIS; TESTIS; SPERMATOGENESIS; STEROIDOGENESIS	The process of spermatogenesis is a complex and delicate process that is still not fully understood. In this study, we examined the role of fatty acid oxidase 3-hydroxy acyl CoA dehydrogenase (HADH) in maintaining normal spermatogenesis in mice. In male mice, ablation of the Hadh gene using CRISPR/Cas9 technology arrested spermatocyte meiosis, increased multinucleated giant germ cells and vacuoles in seminiferous tubules, and accompanied with acrosomal dysplasia. Hadh(-/-) male mice showed the typical features of oligoasthenoteratozoospermia (OAT), including decreased sperm concentration and motility and increased sperm abnormalities. Next, we explored the molecular events in the testes of the mutant mice. We found fatty acids accumulated in the testis of Hadh(-/-) mice. And also, inflammatory factors TNF-alpha, IL-1 beta, and IL-6 were significantly increased, apoptosis-related protein Bcl-2 was decreased, and Bax and cleaved-Caspase3 were increased in Hadh(-/-) male mice testis. After using etanercept, a specific inhibitor of TNF-alpha, testis injury caused by Hadh knockout was significantly alleviated, the sperm quality and motility were improved, and germ cell apoptosis was reduced. So our study demonstrated that Hadh deletion caused an increase in fatty acids. The accumulated fatty acids further induced testicular inflammation and germ cell apoptosis through the TNF-alpha/Bcl-2 signaling pathway, finally resulting in OAT in the Hadh(-/-) mice. Inhibiting TNF-alpha may be used as a new treatment approach for testicular inflammation and OAT.	[Zhu, Haixia; Wang, Hongxiang; Cheng, Yin; Liu, Dongyue; Zhang, Aizhen; Gao, Jiangang] Shandong Univ, Sch Life Sci, Jinan 250100, Peoples R China; [Zhu, Haixia; Wang, Hongxiang; Cheng, Yin; Liu, Dongyue; Zhang, Aizhen; Gao, Jiangang] Shandong Univ, Key Lab Minist Educ Expt Teratol, Jinan 250100, Peoples R China; [Wen, Zongzhuang; Gao, Jiangang] Shandong First Med Univ, Med Sci & Technol Innovat Ctr, Jinan 250117, Peoples R China	Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences	Gao, JA (corresponding author), Shandong Univ, Sch Life Sci, Jinan 250100, Peoples R China.; Gao, JA (corresponding author), Shandong Univ, Key Lab Minist Educ Expt Teratol, Jinan 250100, Peoples R China.; Wen, ZZ; Gao, JA (corresponding author), Shandong First Med Univ, Med Sci & Technol Innovat Ctr, Jinan 250117, Peoples R China.	wenzongzhuang@sdfmu.edu.cn; jggao@sdu.edu.cn			MOST | National Key Research and Development Program of China [2018YFC1003602]	MOST | National Key Research and Development Program of China	MOST | National Key Research and Development Program of China (NKPs), Grant/Award Number: 2018YFC1003602	Baarends WM, 2005, MOL CELL BIOL, V25, P1041, DOI 10.1128/MCB.25.3.1041-1053.2005; Babakhanzadeh E, 2020, INT J GEN MED, V13, P29, DOI 10.2147/IJGM.S241099; Beurois J, 2020, BEST PRACT RES CL EN, V34, DOI 10.1016/j.beem.2020.101473; Cao ZH, 2013, CELL BIOCHEM BIOPHYS, V67, P1239, DOI 10.1007/s12013-013-9642-4; Cao Z, 2020, ENVIRON POLLUT, V264, DOI 10.1016/j.envpol.2020.114748; Cavallini G, 2006, ASIAN J ANDROL, V8, P143, DOI 10.1111/j.1745-7262.2006.00123.x; DE SK, 1993, ENDOCRINOLOGY, V133, P389, DOI 10.1210/en.133.1.389; Du ZX, 2021, SCI PROGRESS-UK, V104, DOI 10.1177/00368504211011344; Dutta S, 2022, REPROD SCI, V29, P2707, DOI 10.1007/s43032-021-00721-0; Elliott MR, 2010, NATURE, V467, P333, DOI 10.1038/nature09356; Foomani FH, 2021, IEEE J TRANSL ENG HE, V9, P1, DOI 10.1109/JTEHM.2021.3104966; Fritsche KL, 2015, ADV NUTR, V6, p293S, DOI 10.3945/an.114.006940; Fu YF, 2002, ACTA BIOCH BIOPH SIN, V34, P389; Gao Q, 2020, J BIOL CHEM, V295, P6289, DOI 10.1074/jbc.RA119.012375; Guzick DS, 2001, NEW ENGL J MED, V345, P1388, DOI 10.1056/NEJMoa003005; Hedger MP, 2011, J ANDROL, V32, P625, DOI 10.2164/jandrol.111.012989; Hedger MP, 2003, J REPROD IMMUNOL, V58, P1, DOI 10.1016/S0165-0378(02)00060-8; Heinrich A, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.03.077; Heslegrave AJ, 2013, J CLIN ENDOCR METAB, V98, P496, DOI 10.1210/jc.2012-3134; HOLSTEIN AF, 1986, ANDROLOGIA, V18, P5; Houten SM, 2016, ANNU REV PHYSIOL, V78, P23, DOI 10.1146/annurev-physiol-021115-105045; Huang T, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2235-4; Hwang DH, 2016, EUR J PHARMACOL, V785, P24, DOI 10.1016/j.ejphar.2016.04.024; Jha KN, 2017, J CELL SCI, V130, P1835, DOI 10.1242/jcs.202721; Jiang HM, 2021, GENOMICS, V113, P3556, DOI 10.1016/j.ygeno.2021.08.008; Kapoor RR, 2010, REV ENDOCR METAB DIS, V11, P185, DOI 10.1007/s11154-010-9148-y; Li ZB, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.725933; Liu Q, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03755-z; Lu XS, 2018, J CELL BIOCHEM, V119, P4760, DOI 10.1002/jcb.26668; MACGREGOR GR, 1990, P NATL ACAD SCI USA, V87, P5016, DOI 10.1073/pnas.87.13.5016; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Maltesen HR, 2010, RHEUMATOLOGY, V49, P2037, DOI 10.1093/rheumatology/keq213; MIETHING A, 1993, ANDROLOGIA, V25, P317; Pelechas E, 2019, EXPERT OPIN BIOL TH, V19, P173, DOI 10.1080/14712598.2019.1566456; Rogero MM, 2018, NUTRIENTS, V10, DOI 10.3390/nu10040432; Sadasivam M, 2015, INFLAMM RES, V64, P549, DOI 10.1007/s00011-015-0835-8; Schlatt S, 1997, EUR J ENDOCRINOL, V137, P107, DOI 10.1530/eje.0.1370107; Schuppe HC, 2005, CHEM IMMUNOL ALLERGY, V88, P1, DOI 10.1159/000087816; Shen CC, 2017, ONCOTARGET, V8, P76279, DOI 10.18632/oncotarget.19348; Snodgrass RG, 2013, J IMMUNOL, V191, P4337, DOI 10.4049/jimmunol.1300298; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tuttelmann F, 2018, MED GENET-BERLIN, V30, P12, DOI 10.1007/s11825-018-0181-7; Van Antwerp DJ, 1998, TRENDS CELL BIOL, V8, P107, DOI 10.1016/S0962-8924(97)01215-4; Varuzhanyan G, 2021, DEVELOPMENT, V148, DOI 10.1242/dev.199686; Vertika S, 2020, MITOCHONDRION, V54, P26, DOI 10.1016/j.mito.2020.06.003; Wen ZZ, 2020, EXP CELL RES, V395, DOI 10.1016/j.yexcr.2020.112178; Wettersten HI, 2017, NAT REV NEPHROL, V13, P410, DOI 10.1038/nrneph.2017.59; Willis S, 2003, J CELL SCI, V116, P4053, DOI 10.1242/jcs.00754; XIONG YT, 1993, ENDOCRINOLOGY, V133, P2568, DOI 10.1210/en.133.6.2568; Yeung CH, 2002, BIOL REPROD, V67, P269, DOI 10.1095/biolreprod67.1.269; Zerbini CAF, 2017, OSTEOPOROSIS INT, V28, P429, DOI 10.1007/s00198-016-3769-2; ZHANG Y, 2021, FRONTIERS MOL BIOSCI, V0008; Zhao JL, 2017, GEN COMP ENDOCR, V252, P48, DOI 10.1016/j.ygcen.2017.07.013	53	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22661	10.1096/fj.202201144R	http://dx.doi.org/10.1096/fj.202201144R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6L3ID	36398584				2022-12-26	WOS:000888079000001
J	Zheng, Y; Zhao, TJ; Wang, JR; Jiang, RZ; Huang, JB; Li, WM; Wang, JH				Zheng, Yang; Zhao, Tiejian; Wang, Jiaru; Jiang, Ruizhu; Huang, Jinbiao; Li, Weimin; Wang, Jiahui			Curcumol alleviates liver fibrosis through inducing autophagy and ferroptosis in hepatic stellate cells	FASEB JOURNAL			English	Article						autophagy; curcumol; ferroptosis; hepatic fibrosis; NCOA4; therapeutic target	FERRITINOPHAGY; FIBROGENESIS; ACTIVATION; PROMOTES; DEATH	To explore the effect of curcumol on autophagy and ferroptosis of hepatic stellate cells, and to clarify the molecular mechanism of its anti-hepatic fibrosis. In the present study, we report that curcumol promotes the death of activated HSCs and reduces the deposition of extracellular matrix. Interestingly, curcumol treatment can trigger ferroptosis to eliminate activated HSCs characterized by iron overload, lipid ROS accumulation, glutathione depletion, and lipid peroxidation. Curcumol promotes HSC autophagy, which may be the key mechanism for its induction of ferroptosis. It is worth noting that the upregulation of nuclear receptor coactivator 4 (NCOA4) may play a key molecular mechanism. NCOA4 mediates the release of iron ions and induces the occurrence of ferroptosis. Overall, curcumol promotes autophagy in hepatic stellate cells, mediates the degradation of NCOA4 and FTH1 complexes, releases iron ions, leads to iron overload, and induces ferroptosis, which may be an important mechanism for its anti-hepatic fibrosis effect.	[Zheng, Yang; Jiang, Ruizhu; Huang, Jinbiao; Wang, Jiahui] Guangxi Univ Chinese Med, Fac Chinese Med Sci, Dept Med, Nanning 530222, Guangxi, Peoples R China; [Zhao, Tiejian; Wang, Jiaru; Li, Weimin] Guangxi Univ Chinese Med, Coll Basic Med, Nanning 530222, Guangxi, Peoples R China	Guangxi University of Chinese Medicine; Guangxi University of Chinese Medicine	Wang, JH (corresponding author), Guangxi Univ Chinese Med, Fac Chinese Med Sci, Dept Med, Nanning 530222, Guangxi, Peoples R China.; Li, WM (corresponding author), Guangxi Univ Chinese Med, Coll Basic Med, Nanning 530222, Guangxi, Peoples R China.	676057107@qq.com; 344689018@qq.com		zheng, yang/0000-0001-7646-511X	The National Natural Science Foundation of China; Guangxi Natural Science Foundation [82204755, 82160954, 81960751, 81960761, 81660705]; Guangxi Young and Middle- aged Teachers' Research Ability Improvement Project [2020GXNSFBA297094]; Guangxi University of Traditional Chinese Medicine School- level Project Youth Fund [GXZYZZ2020- 07, GXZYZZ2019- 1]; Faculty of Chinese Medicine Science Guangxi University of Chinese Medicine Research Project [2020QN006];  [2022MS008];  [2022QJ001]	The National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); Guangxi Young and Middle- aged Teachers' Research Ability Improvement Project; Guangxi University of Traditional Chinese Medicine School- level Project Youth Fund; Faculty of Chinese Medicine Science Guangxi University of Chinese Medicine Research Project; ; 	The National Natural Science Foundation of China, Grant/Award Number: 82204755, 82160954, 81960751, 81960761 and 81660705; Guangxi Natural Science Foundation, Grant/Award Number: 2020GXNSFBA297094; Guangxi Young and Middle- aged Teachers' Research Ability Improvement Project, Grant/Award Number: 2022KY1667 and 2020KY59009; Guangxi Zhuangyao Pharmaceutical Key Laboratory, Grant/Award Number: GXZYZZ2020- 07 and GXZYZZ2019- 1; Guangxi University of Traditional Chinese Medicine School- level Project Youth Fund, Grant/Award Number: 2020QN006; Faculty of Chinese Medicine Science Guangxi University of Chinese Medicine Research Project, Grant/Award Number: 2022MS008 and 2022QJ001	Azad AI, 2020, HEPATOLOGY, V72, P1013, DOI 10.1002/hep.31211; Bian ML, 2017, BIOFACTORS, V43, P836, DOI 10.1002/biof.1390; Bridle KR, 2003, AM J PATHOL, V162, P1661, DOI 10.1016/S0002-9440(10)64300-3; Cao JY, 2016, CELL MOL LIFE SCI, V73, P2195, DOI 10.1007/s00018-016-2194-1; Chen B, 2019, BRAIN RES BULL, V153, P122, DOI 10.1016/j.brainresbull.2019.08.013; del Rey MQ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00238; Dikic I, 2018, NAT REV MOL CELL BIO, V19, P349, DOI 10.1038/s41580-018-0003-4; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Gao MH, 2016, CELL RES, V26, P1021, DOI 10.1038/cr.2016.95; Gryzik M, 2021, BBA-MOL CELL RES, V1868, DOI 10.1016/j.bbamcr.2020.118913; Gryzik M, 2017, BBA-GEN SUBJECTS, V1861, P2710, DOI 10.1016/j.bbagen.2017.07.015; Hazari Y, 2020, J HEPATOL, V72, P183, DOI 10.1016/j.jhep.2019.08.026; Huang Y, 2017, EXP CELL RES, V352, P420, DOI 10.1016/j.yexcr.2017.02.038; Karvar S, 2020, HEPATOLOGY, V72, P1073, DOI 10.1002/hep.31078; Kong DS, 2020, REDOX BIOL, V36, DOI 10.1016/j.redox.2020.101600; Kong ZY, 2019, BIOMED PHARMACOTHER, V109, P2043, DOI 10.1016/j.biopha.2018.11.030; Lamark T, 2017, ESSAYS BIOCHEM, V61, P609, DOI 10.1042/EBC20170035; Li GY, 2020, PHYTOTHER RES, V34, P1421, DOI 10.1002/ptr.6616; Liu J, 2020, CELL CHEM BIOL, V27, P420, DOI 10.1016/j.chembiol.2020.02.005; Liu JF, 2019, BRIT J PHARMACOL, V176, P4666, DOI 10.1111/bph.14831; Mancias JD, 2014, NATURE, V509, P105, DOI 10.1038/nature13148; Mou YH, 2021, BMC CANCER, V21, DOI 10.1186/s12885-020-07726-z; Omenetti A, 2011, J HEPATOL, V54, P366, DOI 10.1016/j.jhep.2010.10.003; Qi XY, 2021, CELL PROLIFERAT, V54, DOI 10.1111/cpr.13107; Ruddell RG, 2009, HEPATOLOGY, V49, P887, DOI 10.1002/hep.22716; Shan L, 2019, INT IMMUNOPHARMACOL, V75, DOI 10.1016/j.intimp.2019.105765; Shi BH, 2019, J CELL PHYSIOL, V234, P12562, DOI 10.1002/jcp.28125; Song J, 2018, J PHARM PHARMACOL, V70, P393, DOI 10.1111/jphp.12877; Stoyanovsky DA, 2019, FREE RADICAL BIO MED, V133, P153, DOI 10.1016/j.freeradbiomed.2018.09.008; Su LJ, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/5080843; Tang MZ, 2018, J CELL PHYSIOL, V233, P9179, DOI 10.1002/jcp.26954; Tian Y, 2020, NEUROTHERAPEUTICS, V17, P1796, DOI 10.1007/s13311-020-00929-z; Xiu ZR, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.930958; Xu HD, 2019, ADV EXP MED BIOL, V1206, P109, DOI 10.1007/978-981-15-0602-4_5; Yang WS, 2016, TRENDS CELL BIOL, V26, P165, DOI 10.1016/j.tcb.2015.10.014; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Yi JZ, 2021, CELL DEATH DISCOV, V7, DOI 10.1038/s41420-021-00768-7; Zhang CY, 2016, WORLD J GASTROENTERO, V22, P10512, DOI 10.3748/wjg.v22.i48.10512; Zhang ZL, 2021, BIOFACTORS, V47, P801, DOI 10.1002/biof.1764; Zhang ZL, 2020, AUTOPHAGY, V16, P1482, DOI 10.1080/15548627.2019.1687985; Zhang ZL, 2018, AUTOPHAGY, V14, P2083, DOI 10.1080/15548627.2018.1503146; Zhang ZL, 2017, REDOX BIOL, V11, P322, DOI 10.1016/j.redox.2016.12.021; Zheng Y, 2020, EVID-BASED COMPL ALT, V2020, DOI 10.1155/2020/8590638; 郑洋, 2021, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V32, P58	44	0	0	7	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22665	10.1096/fj.202200933RR	http://dx.doi.org/10.1096/fj.202200933RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6L3FG	36398583				2022-12-26	WOS:000888071500001
J	Capitini, C; Pesce, L; Fani, G; Mazzamuto, G; Genovese, M; Franceschini, A; Paoli, P; Pieraccini, G; Zasloff, M; Chiti, F; Pavone, FS; Calamai, M				Capitini, Claudia; Pesce, Luca; Fani, Giulia; Mazzamuto, Giacomo; Genovese, Massimo; Franceschini, Alessandra; Paoli, Paolo; Pieraccini, Giuseppe; Zasloff, Michael; Chiti, Fabrizio; Pavone, Francesco S.; Calamai, Martino			Studying the trafficking of labeled trodusquemine and its application as nerve marker for light-sheet and expansion microscopy	FASEB JOURNAL			English	Article						intracellular trafficking; lipid membrane; nerve fiber staining; neurodegeneration; optical imaging; squalamine	ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; SQUALAMINE; PROTEINS; CHOLESTEROL; GENERATION; ORGANELLES; OLIGOMERS; DYNAMICS; PHASE	Trodusquemine is an aminosterol with a variety of biological and pharmacological functions, such as acting as an antimicrobial, stimulating body weight loss and interfering with the toxicity of proteins involved in the development of Alzheimer's and Parkinson's diseases. The mechanisms of interaction of aminosterols with cells are, however, still largely uncharacterized. Here, by using fluorescently labeled trodusquemine (TRO-A594 and TRO-ATTO565), we show that trodusquemine binds initially to the plasma membrane of living cells, that the binding affinity is dependent on cholesterol, and that trodusquemine is then internalized and mainly targeted to lysosomes after internalization. We also found that TRO-A594 is able to strongly and selectively bind to myelinated fibers in fixed mouse brain slices, and that it is a marker compatible with tissue clearing and light-sheet fluorescence microscopy or expansion microscopy. In conclusion, this work contributes to further characterize the biology of aminosterols and provides a new tool for nerve labeling suitable for the most advanced microscopy techniques.	[Capitini, Claudia; Pesce, Luca; Mazzamuto, Giacomo; Franceschini, Alessandra; Pavone, Francesco S.; Calamai, Martino] Univ Florence, European Lab Nonlinear Spect LENS, Sesto Fiorentino, Italy; [Capitini, Claudia; Pesce, Luca; Mazzamuto, Giacomo; Franceschini, Alessandra; Pavone, Francesco S.] Univ Florence, Dept Phys, Sesto Fiorentino, Italy; [Fani, Giulia; Genovese, Massimo; Paoli, Paolo; Chiti, Fabrizio] Univ Florence, Dept Expt & Clin Biomed Sci, Sect Biochem, Florence, Italy; [Mazzamuto, Giacomo; Pavone, Francesco S.; Calamai, Martino] Natl Res Council CNR INO, Natl Inst Opt, Sesto Fiorentino, Italy; [Pieraccini, Giuseppe] Univ Florence, CISM Mass Spectrometry Ctr, Sesto Fiorentino, Italy; [Zasloff, Michael] Enterin Inc, Philadelphia, PA USA; [Zasloff, Michael] Georgetown Univ, MedStar Georgetown Transplant Inst, Sch Med, Washington, DC USA	University of Florence; University of Florence; University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale di Ottica (INO-CNR); University of Florence; Georgetown University	Calamai, M (corresponding author), Univ Florence, European Lab Nonlinear Spect LENS, Sesto Fiorentino, Italy.	calamai@lens.unifi.it			European Union; General Hospital Corporation Center of the National Institutes of Health [654148];  [MH117023]	European Union(European Commission); General Hospital Corporation Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 	European Union & apos;s Horizon 2020 research and innovation programme, Grant/Award Number: 654148 Laserlab- Europe; General Hospital Corporation Center of the National Institutes of Health, Grant/Award Number: MH117023	A. H.Marblestone, 2019, bioRxiv, DOI 10.1101/829903; Ahima RS, 2002, DIABETES, V51, P2099, DOI 10.2337/diabetes.51.7.2099; Alexander RT, 2011, EMBO J, V30, P679, DOI 10.1038/emboj.2010.356; Asano Shoh M, 2018, Curr Protoc Cell Biol, V80, pe56, DOI 10.1002/cpcb.56; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Behrendt G, 2013, GLIA, V61, P273, DOI 10.1002/glia.22432; Bianchini P, 2021, METHOD CELL BIOL, V161, P275, DOI 10.1016/bs.mcb.2020.07.001; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bourebaba L, 2021, STEM CELL RES THER, V12, DOI 10.1186/s13287-020-02102-x; Chen F, 2015, SCIENCE, V347, P543, DOI 10.1126/science.1260088; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; Chozinski TJ, 2016, NAT METHODS, V13, P485, DOI [10.1038/NMETH.3833, 10.1038/nmeth.3833]; Costantini I, 2021, BIOMED OPT EXPRESS, V12, P3684, DOI 10.1364/BOE.415555; Costantini I, 2015, SCI REP-UK, V5, DOI 10.1038/srep09808; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; De Strooper B, 2016, CELL, V164, P603, DOI 10.1016/j.cell.2015.12.056; Desai MK, 2011, GLIA, V59, P627, DOI 10.1002/glia.21131; Errico S, 2021, ACS CHEM NEUROSCI, V12, P3189, DOI 10.1021/acschemneuro.1c00327; Errico S, 2020, NANOSCALE, V12, P22596, DOI 10.1039/d0nr05285j; Falcon-Perez JM, 2005, J CELL SCI, V118, P5243, DOI 10.1242/jcs.02633; Fani G, 2021, ACS CHEM NEUROSCI, V12, P766, DOI 10.1021/acschemneuro.0c00811; FARMER JA, 1992, CLIN THER, V14, P708; Gallagher BR, 2021, NEUROBIOL DIS, V154, DOI 10.1016/j.nbd.2021.105362; Gao MF, 2021, METHOD CELL BIOL, V161, P15, DOI 10.1016/bs.mcb.2020.06.001; Higgins RD, 2000, INVEST OPHTH VIS SCI, V41, P1507; Jensen KHR, 2016, SCI REP-UK, V6, DOI 10.1038/srep32674; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Krishnan N, 2014, NAT CHEM BIOL, V10, P558, DOI [10.1038/NCHEMBIO.1528, 10.1038/nchembio.1528]; Lai HM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03359-w; Lantz KA, 2010, OBESITY, V18, P1516, DOI 10.1038/oby.2009.444; Lawe DC, 2000, J BIOL CHEM, V275, P3699, DOI 10.1074/jbc.275.5.3699; Limbocker R, 2022, NAT PROD REP, V39, P742, DOI 10.1039/d1np00042j; Limbocker R, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.680026; Limbocker R, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01140-8; Limbocker R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07699-5; Madler S, 2009, J MASS SPECTROM, V44, P694, DOI 10.1002/jms.1544; MANDERS EMM, 1992, J CELL SCI, V103, P857; Migneault I, 2004, BIOTECHNIQUES, V37, P790, DOI 10.2144/04375RV01; MOORE KS, 1993, P NATL ACAD SCI USA, V90, P1354, DOI 10.1073/pnas.90.4.1354; Murray E, 2015, CELL, V163, P1500, DOI 10.1016/j.cell.2015.11.025; Nasrabady SE, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0515-3; Nickerson DP, 2012, TRAFFIC, V13, P1411, DOI 10.1111/j.1600-0854.2012.01390.x; Ottana R, 2019, BIOORG CHEM, V92, DOI 10.1016/j.bioorg.2019.103211; Pearson K, 1902, BIOMETRIKA, V2, P357; Pedersen TR, 1998, CIRCULATION, V97, P1453, DOI 10.1161/01.CIR.97.15.1453; Perni M, 2018, ACS CHEM BIOL, V13, P2308, DOI 10.1021/acschembio.8b00466; Perni M, 2017, P NATL ACAD SCI USA, V114, pE1009, DOI 10.1073/pnas.1610586114; Pesce L, 2022, COMMUN BIOL, V5, DOI 10.1038/s42003-022-03390-0; Pesce L, 2019, J BIOPHOTONICS, V12, DOI 10.1002/jbio.201900018; Rao MN, 2000, J NAT PROD, V63, P631, DOI 10.1021/np990514f; Ricke KM, 2020, J NEUROSCI, V40, P1581, DOI 10.1523/JNEUROSCI.2120-19.2019; Sakagami K, 2018, MOL PHARMACEUT, V15, P1332, DOI 10.1021/acs.molpharmaceut.7b01130; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Sills AK, 1998, CANCER RES, V58, P2784; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Tillberg PW, 2016, NAT BIOTECHNOL, V34, P987, DOI 10.1038/nbt.3625; Wassie AT, 2019, NAT METHODS, V16, P33, DOI 10.1038/s41592-018-0219-4; WEHRLI SL, 1993, STEROIDS, V58, P370, DOI 10.1016/0039-128X(93)90040-T; Wen G, 2020, ACS NANO, V14, P7860, DOI 10.1021/acsnano.9b09259; Williams JI, 2001, CLIN CANCER RES, V7, P724; Zasloff M, 2001, INT J OBESITY, V25, P689, DOI 10.1038/sj.ijo.0801599; Zasloff M, 2011, P NATL ACAD SCI USA, V108, P15978, DOI 10.1073/pnas.1108558108; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhao H, 2018, CANCER RES, V78, P2115, DOI 10.1158/0008-5472.CAN-17-3202	65	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22655	10.1096/fj.202201276R	http://dx.doi.org/10.1096/fj.202201276R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6O1NC	36421008				2022-12-26	WOS:000890011200001
J	Ampong, I; Zimmerman, KD; Perumalla, DS; Wallis, KE; Li, G; Huber, HF; Li, C; Nathanielsz, PW; Cox, LA; Olivier, M				Ampong, Isaac; Zimmerman, Kip D.; Perumalla, Danu S.; Wallis, Katharyn E.; Li, Ge; Huber, Hillary F.; Li, Cun; Nathanielsz, Peter W.; Cox, Laura A.; Olivier, Michael			Maternal obesity alters offspring liver and skeletal muscle metabolism in early post-puberty despite maintaining a normal post-weaning dietary lifestyle	FASEB JOURNAL			English	Article						developmental programming; maternal obesity; metabolic disorders; metabolism; metabolomics	FATTY LIVER; METABOLOMICS; BABOONS	Maternal obesity (MO) during pregnancy is linked to increased and premature risk of age-related metabolic diseases in the offspring. However, the underlying molecular mechanisms still remain not fully understood. Using a well-established nonhuman primate model of MO, we analyzed tissue biopsies and plasma samples obtained from post-pubertal offspring (3-6.5 y) of MO mothers (n = 19) and from control animals born to mothers fed a standard diet (CON, n = 13). All offspring ate a healthy chow diet after weaning. Using untargeted gas chromatography-mass spectrometry metabolomics analysis, we quantified a total of 351 liver, 316 skeletal muscle, and 423 plasma metabolites. We identified 58 metabolites significantly altered in the liver and 46 in the skeletal muscle of MO offspring, with 8 metabolites shared between both tissues. Several metabolites were changed in opposite directions in males and females in both liver and skeletal muscle. Several tissue-specific and 4 shared metabolic pathways were identified from these dysregulated metabolites. Interestingly, none of the tissue-specific metabolic changes were reflected in plasma. Overall, our study describes characteristic metabolic perturbations in the liver and skeletal muscle in MO offspring, indicating that metabolic programming in utero persists postnatally, and revealing potential novel mechanisms that may contribute to age-related metabolic diseases later in life.	[Ampong, Isaac; Zimmerman, Kip D.; Perumalla, Danu S.; Wallis, Katharyn E.; Li, Ge; Cox, Laura A.; Olivier, Michael] Wake Forest Univ Sch Med, Ctr Precis Med, Winston Salem, NC 27157 USA; [Ampong, Isaac; Zimmerman, Kip D.; Perumalla, Danu S.; Wallis, Katharyn E.; Cox, Laura A.; Olivier, Michael] Wake Forest Univ Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC USA; [Huber, Hillary F.; Nathanielsz, Peter W.; Cox, Laura A.] Southwest Natl Primate Res Ctr, Texas Biomed Res Inst, San Antonio, TX USA; [Li, Cun; Nathanielsz, Peter W.] Univ Wyoming, Ctr Pregnancy & Newborn Res, Laramie, WY USA	Wake Forest University; Wake Forest University; Texas Biomedical Research Institute; University of Wyoming	Ampong, I; Olivier, M (corresponding author), Wake Forest Univ Sch Med, Ctr Precis Med, Winston Salem, NC 27157 USA.	iampong@wakehealth.edu; molivier@wakehealth.edu		Olivier, Michael/0000-0003-1632-1063	National Institute of Health (NIH);  [U19 AG057758]	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 	ACKNOWLEDGMENTS This work was funded by the National Institute of Health (NIH) grant U19 AG057758 to PWN, LAC, and MO. The authors would like to also acknowledge the Texas Biomedical Research Institute staff for the veterinary services and animal maintenance support.	Alfaradhi MZ, 2014, AM J PHYSIOL-REG I, V307, pR26, DOI 10.1152/ajpregu.00049.2014; Ampong I, 2022, METABOLITES, V12, DOI 10.3390/metabo12050429; Ashrafian H, 2021, MED PRIN PRACT, V30, P301, DOI 10.1159/000513545; Cao KAL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-253; Chen C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202183; Chong Jasmine, 2019, Curr Protoc Bioinformatics, V68, pe86, DOI 10.1002/cpbi.86; Cox LA, 2017, ILAR J, V58, P235, DOI 10.1093/ilar/ilx025; Cox LA, 2013, ILAR J, V54, P106, DOI 10.1093/ilar/ilt038; Fiehn O, 2008, PLANT J, V53, P691, DOI 10.1111/j.1365-313X.2007.03387.x; Glastras SJ, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180050; Higgins PB, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-71; Jin R, 2016, J PEDIATR-US, V172, P14, DOI 10.1016/j.jpeds.2016.01.026; Kurt Z, 2018, BIOL SEX DIFFER, V9, DOI 10.1186/s13293-018-0205-7; Leon-Aguilar LF, 2019, INT J OBESITY, V43, P1231, DOI 10.1038/s41366-018-0291-y; Li C, 2019, J MED PRIMATOL, V48, P90, DOI 10.1111/jmp.12396; Li M, 2011, EXP DIABETES RES, DOI [10.1155/2011/592408, 10.4061/2011/179819]; Long NM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122152; Lynch C, 2017, J DEV ORIG HLTH DIS, V8, P263, DOI 10.1017/S2040174416000805; Mahaney MC, 2018, J MED PRIMATOL, V47, P3, DOI 10.1111/jmp.12283; McCoski S, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11082216; Misra BB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214487; Nathanielsz PW, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12564; Nelson SM, 2010, HUM REPROD UPDATE, V16, P255, DOI 10.1093/humupd/dmp050; Romijn JA, 2009, J PHYSIOL-LONDON, V587, P1637, DOI 10.1113/jphysiol.2009.171868; Safi-Stibler S, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061572; Schoonejans JM, 2021, DIABETIC MED, V38, DOI 10.1111/dme.14694; Snow SJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73361-0; Tsugawa H, 2015, NAT METHODS, V12, P523, DOI 10.1038/nmeth.3393; Viant MR, 2017, CURR OPIN CHEM BIOL, V36, P64, DOI 10.1016/j.cbpa.2017.01.001; Wang QR, 2019, FASEB J, V33, P2587, DOI 10.1096/fj.201800988R; Zhou YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132088; Zhu NL, 2021, METABOLITES, V11, DOI 10.3390/metabo11060374	32	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22644	10.1096/fj.202201473R	http://dx.doi.org/10.1096/fj.202201473R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6L1PL	36415994				2022-12-26	WOS:000887962200001
J	Jiang, XX; Zhang, K; Gao, CY; Ma, WZ; Liu, MQ; Guo, XY; Bao, GW; Han, B; Hu, H; Zhao, ZH				Jiang, Xixi; Zhang, Kaina; Gao, Chenying; Ma, Wenzhuo; Liu, Mengqing; Guo, Xinyu; Bao, Gaowa; Han, Bing; Hu, Hao; Zhao, Zhenghang			Activation of FMS-like tyrosine kinase 3 protects against isoprenaline-induced cardiac hypertrophy by improving autophagy and mitochondrial dynamics	FASEB JOURNAL			English	Article						autophagy; cardiac hypertrophy; FMS-like receptor tyrosine kinase 3; isoprenaline; mitochondrial dynamics	LYSOSOMAL BIOGENESIS; IN-VITRO; FLT3; SIRT1; DEACETYLATION; PROMOTES; HEART; DEGRADATION; EXPRESSION; PROGENITOR	FMS-like receptor tyrosine kinase 3 (Flt3) expression was reported to increase in the heart in response to pathological stress, but the role of Flt3 activation and its underlying mechanisms remain poorly elucidated. This study was designed to investigate the role of Flt3 activation in sympathetic hyperactivity-induced cardiac hypertrophy and its mechanisms through autophagy and mitochondrial dynamics. In vivo, cardiac hypertrophy was established by subcutaneous injection of isoprenaline (6 mg/kg center dot day) in C57BL/6 mice for 7 consecutive days. The Flt3-ligand intervention was launched 2 h prior to isoprenaline each day. In vitro, experiments of cardiomyocyte hypertrophy, autophagy, and mitochondrial dynamics were performed in neonatal rat cardiomyocytes (NRCMs). Our results revealed that the expression level of Flt3 protein was significantly increased in the hypertrophic myocardium provoked by isoprenaline administration. Flt3-ligand intervention alleviated isoprenaline-induced cardiac oxidative stress, hypertrophy, fibrosis, and contractile dysfunction. Isoprenaline stimulation impaired autophagic flux in hypertrophic mouse hearts, supported by the accumulation of LC3II and P62 proteins, while Flt3-ligand restored the impairment of autophagic flux. Flt3 activation normalized the imbalance of mitochondrial fission and fusion in the hearts of mice evoked by isoprenaline as evidenced by the neutralization of elevated mitochondrial fission markers and reduced mitochondrial fusion markers. In NRCMs, Flt3-ligand treatment attenuated isoprenaline-stimulated hypertrophy, which was abolished by a Flt3-specific blocker AC220. Activating Flt3 reversed isoprenaline-induced autophagosome accumulation and impairment of autophagic flux probably by enhancing SIRT1 expression and consequently TFEB nuclear translocation. Flt3 activation improved the imbalance of mitochondrial dynamics induced by isoprenaline in NRCMs through the SIRT1/P53 pathway. Activation of Flt3 mitigated ISO-stimulated hypertrophy probably involves the restoration of autophagic flux and balance of mitochondrial dynamics. Therefore, activation of Flt3 attenuates isoprenaline-induced cardiac hypertrophy in vivo and in vitro, the potential mechanism probably attributes to SIRT1/TFEB-mediated autophagy promotion and SIRT1/P53-mediated mitochondrial dynamics balance. These findings suggest that activation of Flt3 may be a novel target for protection against cardiac remodeling and heart failure during sympathetic hyperactivity.	[Jiang, Xixi; Zhang, Kaina; Gao, Chenying; Ma, Wenzhuo; Liu, Mengqing; Guo, Xinyu; Bao, Gaowa; Han, Bing; Hu, Hao; Zhao, Zhenghang] Xi An Jiao Tong Univ, Sch Basic Med Sci, Dept Pharmacol, Hlth Sci Ctr, Xian 710061, Peoples R China	Xi'an Jiaotong University	Zhao, ZH (corresponding author), Xi An Jiao Tong Univ, Sch Basic Med Sci, Dept Pharmacol, Hlth Sci Ctr, Xian 710061, Peoples R China.	zzh@mail.xjtu.edu.cn		zhenghang, Zhao/0000-0003-0421-2046	National Natural Science Foundation of China (NSFC) [81470510, 82270296]; Natural Science Foundation of Shanxi Province (Shanxi Province Natural Science Foundation) [2020JM- 029]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanxi Province (Shanxi Province Natural Science Foundation)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81470510 and 82270296; Natural Science Foundation of Shanxi Province (Shanxi Province Natural Science Foundation), Grant/Award Number: 2020JM- 029	Aung LHH, 2021, MOL THER-NUCL ACIDS, V25, P416, DOI 10.1016/j.omtn.2021.06.006; Ayach BB, 2006, P NATL ACAD SCI USA, V103, P2304, DOI 10.1073/pnas.0510997103; Bao JT, 2016, PROTEIN CELL, V7, P417, DOI 10.1007/s13238-016-0269-2; Bertero E, 2018, NAT REV CARDIOL, V15, P457, DOI 10.1038/s41569-018-0044-6; Chen L, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003012; Chen L, 2009, CARDIOVASC RES, V84, P91, DOI 10.1093/cvr/cvp181; DELAPEYRIERE O, 1995, DIFFERENTIATION, V58, P351, DOI 10.1046/j.1432-0436.1995.5850351.x; Della Verde G, 2021, LIFE SCI ALLIANCE, V5, DOI 10.26508/lsa.202101112; Ding W, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.587438; Disatnik MH, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000461; Dong FF, 2022, FEBS J, V289, P262, DOI 10.1111/febs.16138; Fang L, 2007, LIFE SCI, V80, P2154, DOI 10.1016/j.lfs.2007.04.003; Forte M, 2021, BRIT J PHARMACOL, V178, P2060, DOI 10.1111/bph.15068; Gharanei M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077713; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Givvimani S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032388; Gyongyosi A, 2019, CURR PHARM DESIGN, V25, P2192, DOI 10.2174/1381612825666190619145025; HANNUM C, 1994, NATURE, V368, P643, DOI 10.1038/368643a0; Hariharan N, 2010, CIRC RES, V107, P1470, DOI 10.1161/CIRCRESAHA.110.227371; Hasan P, 2018, J MOL CELL CARDIOL, V121, P103, DOI 10.1016/j.yjmcc.2018.07.004; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Lewis MR, 1914, SCIENCE, V39, P330, DOI 10.1126/science.39.1000.330; Li JC, 2010, PLOS GENET, V6, DOI [10.1371/journal.pgen.1000795, 10.1186/1746-4811-6-1]; Li LF, 2016, ACTA BIOCH BIOPH SIN, V48, P491, DOI 10.1093/abbs/gmw025; Li L, 2014, CELL STEM CELL, V15, P431, DOI 10.1016/j.stem.2014.08.001; Li ZH, 2015, INT J BIOL SCI, V11, P672, DOI 10.7150/ijbs.11883; Lin Jianguo, 2022, Front Cardiovasc Med, V9, P917135, DOI 10.3389/fcvm.2022.917135; Lin ZH, 2012, MOL CELL, V46, P484, DOI 10.1016/j.molcel.2012.03.024; Liu F, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020682; Lu G, 2022, MEDCOMM, V3, DOI 10.1002/mco2.150; LYMAN SD, 1994, BLOOD, V83, P2795, DOI 10.1182/blood.V83.10.2795.2795; Ma SX, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.551318; Ma WZ, 2020, ACTA PHYSIOL, V230, DOI 10.1111/apha.13519; Meeran MFN, 2020, FOOD FUNCT, V11, P965, DOI [10.1039/c9fo00530g, 10.1039/C9FO00530G]; Pfister O, 2014, J AM COLL CARDIOL, V63, P1011, DOI 10.1016/j.jacc.2013.08.1647; Pillai VB, 2014, CIRC RES, V114, P368, DOI 10.1161/CIRCRESAHA.113.300536; Qi J, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00176; Ramirez-Sagredo A, 2021, FASEB J, V35, DOI 10.1096/fj.202002598R; Settembre C, 2011, AUTOPHAGY, V7, P1379, DOI 10.4161/auto.7.11.17166; Shah AK, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10060931; Takahashi Shinichiro, 2020, Leuk Res Rep, V13, P100187, DOI 10.1016/j.lrr.2019.100187; Tran DT, 2022, AM J TRANSPLANT, V22, P386, DOI 10.1111/ajt.16882; Valente AJ, 2017, ACTA HISTOCHEM, V119, P315, DOI 10.1016/j.acthis.2017.03.001; Wang WC, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-04059-y; Wei X, 2015, CIRCULATION, V131, P1506, DOI 10.1161/CIRCULATIONAHA.114.013789; Yu HY, 2011, J CARDIOVASC PHARM T, V16, P205, DOI 10.1177/1074248410385683; Zech ATL, 2020, BBA-MOL CELL RES, V1867, DOI 10.1016/j.bbamcr.2019.01.013; Zepeda R, 2014, J CARDIOVASC PHARM, V63, P477, DOI 10.1097/FJC.0000000000000071; Zhang P, 2022, OXID MED CELL LONGEV, V2022, DOI 10.1155/2022/1121323; Zhang YX, 2017, MOL MED REP, V16, P8253, DOI 10.3892/mmr.2017.7601; Zhang ZL, 2017, BIOMED PHARMACOTHER, V89, P1055, DOI 10.1016/j.biopha.2017.02.103; Zhao JC, 2022, BLOOD REV, V52, DOI 10.1016/j.blre.2021.100905; Zheng YH, 2021, AGING-US, V13, P7096, DOI 10.18632/aging.202566	53	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12								10.1096/fj.202200419RR	http://dx.doi.org/10.1096/fj.202200419RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6R5SA	36440960				2022-12-26	WOS:000892361600019
J	Koizumi, M; Eto, H; Saeki, M; Seki, M; Fukushima, T; Mukai, S; Ide, H; Sera, Y; Iwasaki, M; Suzuki, Y; Tohei, A; Kishi, Y; Honda, H				Koizumi, Miho; Eto, Hikaru; Saeki, Mai; Seki, Masahide; Fukushima, Tsuyoshi; Mukai, Shoichiro; Ide, Hisamitsu; Sera, Yasuyuki; Iwasaki, Masayuki; Suzuki, Yutaka; Tohei, Atsushi; Kishi, Yusuke; Honda, Hiroaki			UTX deficiency in neural stem/progenitor cells results in impaired neural development, fetal ventriculomegaly, and postnatal death	FASEB JOURNAL			English	Article						histone demethylase; hydrocephalus; Kabuki syndrome; neuronal stem; progenitor cells; UTX; ventriculomegaly	H3K27ME3 DEMETHYLASE UTX; READ ALIGNMENT; STEM-CELLS; GENE; KDM6A; EXPRESSION; MUTATIONS; CHROMATIN; MECHANISMS; DIFFERENTIATION	Recent studies have demonstrated that epigenetic modifications are deeply involved in neurogenesis; however, the precise mechanisms remain largely unknown. To determine the role of UTX (also known as KDM6A), a demethylase of histone H3K27, in neural development, we generated Utx-deficient mice in neural stem/progenitor cells (NSPCs). Since Utx is an X chromosome-specific gene, the genotypes are sex-dependent; female mice lose both Utx alleles (Utx(Delta/Delta)), and male mice lose one Utx allele yet retain one Uty allele, the counterpart of Utx on the Y chromosome (Utx(Delta/Uty)). We found that Utx(Delta/Delta) mice exhibited fetal ventriculomegaly and died soon after birth. Immunofluorescence staining and EdU labeling revealed a significant increase in NSPCs and a significant decrease in intermediate-progenitor and differentiated neural cells. Molecular analyses revealed the downregulation of pathways related to DNA replication and increased H3K27me3 levels around the transcription start sites in Utx(Delta/Delta) NSPCs. These results indicate that UTX globally regulates the expression of genes required for proper neural development in NSPCs, and UTX deficiency leads to impaired cell cycle exit, reduced differentiation, and neonatal death. Interestingly, although Utx(Delta/Uty) mice survived the postnatal period, most died of hydrocephalus, a clinical feature of Kabuki syndrome, a congenital anomaly involving UTX mutations. Our findings provide novel insights into the role of histone modifiers in neural development and suggest that Utx(Delta/Uty) mice are a potential disease model for Kabuki syndrome.	[Koizumi, Miho; Sera, Yasuyuki; Iwasaki, Masayuki; Honda, Hiroaki] Tokyo Womens Med Univ, Inst Lab Anim, Field Human Dis Models, Adv Life Sci & Med, 8-1 Kawada Cho,Shinjuku Ku, Tokyo 1628666, Japan; [Eto, Hikaru; Saeki, Mai; Kishi, Yusuke] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan; [Saeki, Mai; Kishi, Yusuke] Univ Tokyo, Inst Quantitat Biosci, Lab Mol Neurobiol, Tokyo, Japan; [Seki, Masahide; Suzuki, Yutaka] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Chiba, Japan; [Fukushima, Tsuyoshi] Univ Miyazaki, Fac Med, Dept Pathol, Sect Oncopathol & Regenerat Biol, Miyazaki, Japan; [Mukai, Shoichiro] Univ Miyazaki, Fac Med, Dept Urol, Miyazaki, Japan; [Ide, Hisamitsu] Dokkyo Med Univ, Saitama Med Ctr, Dept Urol, Saitama, Japan; [Tohei, Atsushi] Nippon Vet & Life Sci Univ, Lab Expt Anim Sci, Tokyo, Japan; [Kishi, Yusuke] Univ Tokyo, Inst Quantitat Biosci, 1-1-1 Yayoi,Bunkyo Ku, Tokyo 1130032, Japan	Tokyo Women's Medical University; University of Tokyo; University of Tokyo; University of Tokyo; University of Miyazaki; University of Miyazaki; Dokkyo Medical University; Nippon Veterinary & Life Science University; University of Tokyo	Honda, H (corresponding author), Tokyo Womens Med Univ, Inst Lab Anim, Field Human Dis Models, Adv Life Sci & Med, 8-1 Kawada Cho,Shinjuku Ku, Tokyo 1628666, Japan.; Kishi, Y (corresponding author), Univ Tokyo, Inst Quantitat Biosci, 1-1-1 Yayoi,Bunkyo Ku, Tokyo 1130032, Japan.	ykisi@iqb.u-tokyo.ac.jp; honda.hiroaki@twmu.ac.jp			AMED-PRIME [JP22gm6110021]; KAKENHI [JP20H03179, 19K22546, 21H00242, 22H04687, 16H06279]; Secom Science and Technology Foundation (SSTF)	AMED-PRIME; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Secom Science and Technology Foundation (SSTF)	AMED-PRIME, Grant/Award Number: JP22gm6110021; KAKENHI, Grant/Award Number: JP20H03179, 19K22546, 21H00242, 22H04687 and 16H06279; Secom Science and Technology Foundation (SSTF)	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Amemiya T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36636-1; Andricovich J, 2018, CANCER CELL, V33, P512, DOI 10.1016/j.ccell.2018.02.003; Bond AM, 2015, CELL STEM CELL, V17, P385, DOI 10.1016/j.stem.2015.09.003; Boniel S, 2021, GENES-BASEL, V12, DOI 10.3390/genes12040468; Boyle AP, 2008, BIOINFORMATICS, V24, P2537, DOI 10.1093/bioinformatics/btn480; Chakraborty AA, 2019, SCIENCE, V363, P1217, DOI 10.1126/science.aaw1026; Denton D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3916; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eto H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19556-5; Florio M, 2014, DEVELOPMENT, V141, P2182, DOI 10.1242/dev.090571; Ford DJ, 2015, CANCER GENET-NY, V208, P178, DOI 10.1016/j.cancergen.2015.01.005; Gorski JA, 2002, J NEUROSCI, V22, P6309; Gozdecka M, 2018, NAT GENET, V50, P883, DOI 10.1038/s41588-018-0114-z; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Greenfield A, 1998, HUM MOL GENET, V7, P737, DOI 10.1093/hmg/7.4.737; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Guo ZM, 2018, BMC MED GENET, V19, DOI 10.1186/s12881-018-0724-4; Head B, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71760-x; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Isaka F, 1999, EUR J NEUROSCI, V11, P2582, DOI 10.1046/j.1460-9568.1999.00699.x; Jiang W, 2013, CELL RES, V23, P122, DOI 10.1038/cr.2012.119; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Karimy JK, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.8.FOCUS16278; Kaya-Okur HS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09982-5; Kishi Yusuke, 2021, STAR Protoc, V2, P100540, DOI 10.1016/j.xpro.2021.100540; Kobatake K, 2020, CLIN CANCER RES, V26, P2065, DOI 10.1158/1078-0432.CCR-19-2230; Kompanikova P, 2022, CELL MOL LIFE SCI, V79, DOI 10.1007/s00018-022-04314-1; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lederer D, 2012, AM J HUM GENET, V90, P119, DOI 10.1016/j.ajhg.2011.11.021; Lee S, 2012, DEV CELL, V22, P25, DOI 10.1016/j.devcel.2011.11.009; Lei XP, 2018, STEM CELL REP, V10, P1193, DOI 10.1016/j.stemcr.2018.02.008; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liddelow SA, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00032; Liu Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3005; Lun MP, 2015, NAT REV NEUROSCI, V16, P445, DOI 10.1038/nrn3921; Mar BG, 2012, LEUKEMIA, V26, P1881, DOI 10.1038/leu.2012.56; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Miyake N, 2013, HUM MUTAT, V34, P108, DOI 10.1002/humu.22229; Morimoto-Suzki N, 2014, DEVELOPMENT, V141, P4343, DOI 10.1242/dev.112276; Nakagawa T, 2020, GLIA, V68, P1554, DOI 10.1002/glia.23818; Naruse C, 2017, FASEB J, V31, P2252, DOI 10.1096/fj.201600642R; Pereira CF, 2010, CELL STEM CELL, V6, P547, DOI 10.1016/j.stem.2010.04.013; Petruk S, 2017, CELL REP, V19, P295, DOI 10.1016/j.celrep.2017.03.035; Ramos C, 2005, TRENDS GENET, V21, P624, DOI 10.1016/j.tig.2005.09.001; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Seenundun S, 2010, EMBO J, V29, P1401, DOI 10.1038/emboj.2010.37; Sera Y, 2021, BLOOD, V137, P908, DOI 10.1182/blood.2019001044; Shan YL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14028-x; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Shen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065598; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Shpargel KB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002964; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sunabori T, 2008, J CELL SCI, V121, P1204, DOI 10.1242/jcs.025064; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Tang GB, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00267; Tang QY, 2020, STEM CELL REP, V15, P439, DOI 10.1016/j.stemcr.2020.06.015; Telley L, 2019, SCIENCE, V364, P547, DOI 10.1126/science.aav2522; Thieme S, 2013, BLOOD, V121, P2462, DOI 10.1182/blood-2012-08-452003; Torres CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060020; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tsuboi M, 2019, CURR OPIN NEUROBIOL, V59, P164, DOI 10.1016/j.conb.2019.07.003; Tsuboi M, 2018, DEV CELL, V47, P758, DOI 10.1016/j.devcel.2018.11.018; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Umutoni D, 2020, GENES CELLS, V25, P402, DOI 10.1111/gtc.12767; Van der Meulen J, 2014, EPIGENETICS-US, V9, P658, DOI 10.4161/epi.28298; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Walport LJ, 2014, J BIOL CHEM, V289, P18302, DOI 10.1074/jbc.M114.555052; Wang CC, 2012, P NATL ACAD SCI USA, V109, P15324, DOI 10.1073/pnas.1204166109; Wang JK, 2010, GENE DEV, V24, P327, DOI 10.1101/gad.1882610; Welstead GG, 2012, P NATL ACAD SCI USA, V109, P13004, DOI 10.1073/pnas.1210787109; Yamada S, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101058; Yao B, 2016, NAT REV NEUROSCI, V17, P537, DOI 10.1038/nrn.2016.70; Yoo KH, 2016, MOL CELL BIOL, V36, P2108, DOI 10.1128/MCB.00089-16; Yoshii SR, 2016, DEV CELL, V39, P116, DOI 10.1016/j.devcel.2016.09.001	83	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22662	10.1096/fj.202201002RR	http://dx.doi.org/10.1096/fj.202201002RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6L1DN	36412518				2022-12-26	WOS:000887930300001
J	Li, Y; Lin, SB; Xu, X; Jin, WL; Su, YL; Yuan, FQ; Zhang, YT; Li, ZY; Zhou, YH; Zhu, LH; Zhang, L				Li, Yun; Lin, Shibo; Xu, Xu; Jin, Weilai; Su, Yinglin; Yuan, Fuqiang; Zhang, Yiting; Li, Zhengying; Zhou, Yahui; Zhu, Lihong; Zhang, Le			Skeletal muscle HSF1 prevents insulin resistance by improving glucose utilization	FASEB JOURNAL			English	Article						HSF1; insulin sensitivity; myofiber switch; obesity	HEAT-SHOCK FACTOR-1; ACTIVATION; STRESS; HYPERGLYCEMIA; PROTEOSTASIS; ASSOCIATION	The regulation of muscle glucose utilization has significant potential for the treatment of type 2 diabetes mellitus (T2DM) and obesity. Heat shock factor 1 (HSF1) is involved in cellular metabolism and regulation of muscle metabolism. However, it is unclear how HSF1 regulates muscle glucose metabolism. In the present study, the development of obesity in mice was associated with HSF1 downregulation. Serum samples and muscle biopsies were obtained from obese and healthy humans. Fasting glucose and insulin levels and the homeostasis model assessment of insulin resistance value showed that obesity was associated with insulin resistance. The skeletal muscle level of HSF1 was decreased in obese and ob/ob mice. HSF1 was selectively over-expressed in the skeletal muscles of high fat diet (HFD)-fed mice. Muscle HSF1 over-expression successfully triggered glycolytic-to-oxidative myofiber switch and increased fatty acid metabolism and insulin sensitivity in the skeletal muscles of HFD-fed mice. Moreover, HSF1 improved energy expenditure and blocked muscle accumulation of triglycerides in HFD-fed mice. Consequently, muscle HSF1 mitigated the impaired muscle insulin signaling and insulin resistance in HFD-fed mice. In conclusion, T2DM and obesity in HFD-fed mice may be treated with selective HSF1-directed programming of exercise-like effects in skeletal muscle. These findings may aid the development of a new therapeutic approach for obesity and T2DM.	[Li, Yun; Jin, Weilai; Yuan, Fuqiang; Zhang, Yiting] Nanjing Med Univ, Affiliated Wuxi Childrens Hosp, Dept Pediat Lab, Wuxi, Peoples R China; [Lin, Shibo] Nanjing Med Univ, Affiliated Hosp 1, Dept Bariatr & Metab Surg, Nanjing, Peoples R China; [Xu, Xu; Zhu, Lihong] Nanjing Med Univ, Affiliated Wuxi Childrens Hosp, Dept Pediat, Wuxi, Peoples R China; [Su, Yinglin; Li, Zhengying; Zhou, Yahui; Zhang, Le] Nanjing Med Univ, Affiliated Wuxi Childrens Hosp, Dept Neonatol, Wuxi, Peoples R China; [Zhu, Lihong] Nanjing Med Univ, Affiliated Wuxi Childrens Hosp, Dept Pediat, Wuxi 214023, Jiangsu, Peoples R China; [Zhang, Le] Nanjing Med Univ, Affiliated Wuxi Childrens Hosp, Dept Neonatol, Wuxi 214023, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Zhu, LH (corresponding author), Nanjing Med Univ, Affiliated Wuxi Childrens Hosp, Dept Pediat, Wuxi 214023, Jiangsu, Peoples R China.; Zhang, L (corresponding author), Nanjing Med Univ, Affiliated Wuxi Childrens Hosp, Dept Neonatol, Wuxi 214023, Jiangsu, Peoples R China.	lihongzhuwuxi@163.com; zhle@njmu.edu.cn			Medical key discipline program of Wuxi Health commission [ZDXK2021007]; Project of Wuxi health commission [Z202109, M202003]; Top medical expert team of Wuxi Taihu Talent Program [DJTD202106]; Top talent support program for young and middle - aged people of Wuxi Health Committee [BJ2020089]; Wuxi Science and Technology Association [N20202003, N20192039]; National Natural Science Foundation of China [81700744]	Medical key discipline program of Wuxi Health commission; Project of Wuxi health commission; Top medical expert team of Wuxi Taihu Talent Program; Top talent support program for young and middle - aged people of Wuxi Health Committee; Wuxi Science and Technology Association; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Medical key discipline program of Wuxi Health commission, Grant/Award Number: ZDXK2021007; Project of Wuxi health commission, Grant/Award Number: Z202109 and M202003; Top medical expert team of Wuxi Taihu Talent Program, Grant/Award Number: DJTD202106; Top talent support program for young and middle - aged people of Wuxi Health Committee, Grant/Award Number: BJ2020089; Wuxi Science and Technology Association (?????????), Grant/Award Number: N20202003 and N20192039; National Natural Science Foundation of China, Grant/Award Number: 81700744	Amer Diabet Assoc, 2021, DIABETES CARE, V44, pS100, DOI 10.2337/dc21-S008; Batista TM, 2021, DIABETOLOGIA, V64, P994, DOI 10.1007/s00125-021-05415-5; Buse JB, 2020, DIABETES CARE, V43, P487, DOI 10.2337/dci19-0066; Casanova-Vallve N, 2022, MOL METAB, V61, DOI 10.1016/j.molmet.2022.101504; Chang YW, 2021, CELL STRESS CHAPERON, V26, P835, DOI 10.1007/s12192-021-01224-2; Chen ZZ, 2017, DIABETES, V66, P1185, DOI 10.2337/db16-0993; Ciocca DR, 2013, ARCH TOXICOL, V87, P19, DOI 10.1007/s00204-012-0918-z; Dewi FRP, 2021, AUTOPHAGY, V17, P1001, DOI 10.1080/15548627.2020.1741318; Fisher G, 2017, EUR J APPL PHYSIOL, V117, P1413, DOI 10.1007/s00421-017-3634-9; Frampton J, 2020, NAT METAB, V2, P840, DOI 10.1038/s42255-020-0188-7; Gomez-Pastor R, 2018, NAT REV MOL CELL BIO, V19, P4, DOI 10.1038/nrm.2017.73; Gomez-Sanchez L, 2021, J CLIN MED, V10, DOI 10.3390/jcm10245748; Higaki Y, 2008, AM J PHYSIOL-ENDOC M, V294, pE889, DOI 10.1152/ajpendo.00150.2007; Hoff FW, 2021, BLOOD, V137, P1050, DOI 10.1182/blood.2020005208; Isermann T, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24064-1; Karkkainen O, 2019, CARDIOVASC RES, V115, P107, DOI 10.1093/cvr/cvy155; Kruta M, 2021, CELL STEM CELL, V28, P1950, DOI 10.1016/j.stem.2021.07.009; Lewis GF, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI142239; Liebelt F, 2019, CELL REP, V26, P236, DOI 10.1016/j.celrep.2018.12.027; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Liu KS, 2021, EXP THER MED, V21, DOI 10.3892/etm.2021.9624; Ma XR, 2015, CELL METAB, V22, P695, DOI 10.1016/j.cmet.2015.08.005; Maharjan BR, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222413639; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Petersen MC, 2017, NAT REV ENDOCRINOL, V13, P572, DOI 10.1038/nrendo.2017.80; Richter EA, 2001, J PHYSIOL-LONDON, V535, P313, DOI 10.1111/j.1469-7793.2001.t01-2-00313.x; Srivastava P, 2021, FEBS LETT, V595, P1933, DOI 10.1002/1873-3468.14139; Stefan N, 2018, LANCET DIABETES ENDO, V6, P249, DOI 10.1016/S2213-8587(17)30292-9; Sun ZR, 2022, BRIT J PHARMACOL, V179, P1237, DOI 10.1111/bph.15678; ter Horst KW, 2016, METABOLISM, V65, P757, DOI 10.1016/j.metabol.2016.02.010; Tye BW, 2021, MOL BIOL CELL, V32, P1800, DOI 10.1091/mbc.E21-01-0014; Uchiyama T, 2011, METABOLISM, V60, P789, DOI 10.1016/j.metabol.2010.07.029; Valentino L, 2022, RSF-RUS SAGE J SOC S, V8, P89, DOI [10.18311/ti/2021/v28i1/24809, 10.1097/QAD.0000000000003368, 10.1016/j.vaccine.2022.07.056, 10.7758/RSF.2022.8.7.05]; Watanabe K, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22094982; Xirouchaki CE, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abl4988; Xu DQ, 2021, J CACHEXIA SARCOPENI, V12, P192, DOI 10.1002/jcsm.12650; Xu DQ, 2020, J CACHEXIA SARCOPENI, V11, P1306, DOI 10.1002/jcsm.12581; Xu DQ, 2019, J CELL PHYSIOL, V234, P7510, DOI 10.1002/jcp.27512; Xu DQ, 2018, LIFE SCI, V209, P313, DOI 10.1016/j.lfs.2018.08.028; Xu L, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.22; Zhang HC, 2022, NAT CELL BIOL, V24, P340, DOI 10.1038/s41556-022-00846-7	41	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22667	10.1096/fj.202201160RR	http://dx.doi.org/10.1096/fj.202201160RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6O0JE	36421020				2022-12-26	WOS:000889932300001
J	Bian, Y; Li, JP; Shen, HF; Li, YY; Hou, Y; Huang, L; Song, GY; Qiao, C				Bian, Yue; Li, Jiapo; Shen, Hongfei; Li, Yuanyuan; Hou, Yue; Huang, Ling; Song, Guiyu; Qiao, Chong			WTAP dysregulation-mediated HMGN3-m6A modification inhibited trophoblast invasion in early-onset preeclampsia	FASEB JOURNAL			English	Article						early-onset preeclampsia; N6-methyladenosine; preeclampsia; trophoblast; WTAP	RNA M(6)A METHYLATION; BINDING-PROTEIN HMGN3; MESSENGER-RNA; CANCER; CELLS; DIFFERENTIATION; STABILITY	Early-onset preeclampsia (ePE) originates from abnormal implantation and placentation that involves trophoblast invasion, but its pathophysiology is not entirely understood. N6-methyladenosine (m6A) regulators mediate the progression of various cancers. The invasiveness of trophoblast cells is similar to that of tumor cells. However, little is known regarding the potential role of m6A modification in ePE and the underlying mechanism. This study aimed to explore the m6A level in placental tissue samples collected from ePE patients and to investigate whether m6A modification was an essential part of PE pathogenesis. The m6A level in placental tissue samples of 80 PE participants was examined. MeRIP-microarray, RNA-Seq, luciferase reporter assay, and RNA immunoprecipitation chip (RIP) assay were performed. The m6A level in the ePE group was significantly reduced compared with the control group. Wilms' tumor 1-associating protein (WTAP) regulated trophoblast cell migration and invasion. Mechanistically, the high mobility group nucleosomal binding domain 3 (HMGN3) gene was a target gene of WTAP in trophoblast (p < .05). WTAP enhanced the stability of HMGN3 mRNA through binding with its 3'-UTR m6A site(+485A, +522A). HMGN3 was recognized by m6A recognition protein insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1), which was inhibited when knocking down WTAP. Both m6A and WTAP levels were downregulated in ePE. The m6A modification mediated by WTAP/IGF2BP1/HMGN3 axis might contribute to abnormal trophoblast invasion. Our work provided a foundation for further exploration of RNA epigenetic regulatory patterns in ePE, and indicated a new treatment strategy for ePE.	[Bian, Yue; Li, Jiapo; Shen, Hongfei; Li, Yuanyuan; Hou, Yue; Huang, Ling; Song, Guiyu; Qiao, Chong] China Med Univ, Shengjing Hosp, Dept Obstet & Gynecol, Shenyang, Peoples R China; [Bian, Yue; Li, Jiapo; Shen, Hongfei; Li, Yuanyuan; Hou, Yue; Huang, Ling; Song, Guiyu; Qiao, Chong] Key Lab Maternal Fetal Med Liaoning Prov, Shenyang, Peoples R China; [Bian, Yue; Li, Jiapo; Shen, Hongfei; Li, Yuanyuan; Hou, Yue; Huang, Ling; Song, Guiyu; Qiao, Chong] Key Lab Obstet & Gynecol Higher Educ Liaoning Prov, Shenyang, Peoples R China; [Bian, Yue; Li, Jiapo; Shen, Hongfei; Li, Yuanyuan; Hou, Yue; Huang, Ling; Song, Guiyu; Qiao, Chong] China Med Univ Birth Cohort, Res Ctr, Shenyang, Peoples R China	China Medical University	Qiao, C (corresponding author), China Med Univ, Shengjing Hosp, Dept Obstet & Gynecol, Shenyang, Peoples R China.	qiaochong2002@hotmail.com		qiao, chong/0000-0002-4979-3545				[Anonymous], 2019, Obstet Gynecol, V133, P1, DOI 10.1097/AOG.0000000000003018; Barkess G, 2012, BIOCHEM J, V442, P495, DOI 10.1042/BJ20111502; Brown MA, 2018, PREGNANCY HYPERTENS, V13, P291, DOI 10.1016/j.preghy.2018.05.004; Carvajal L, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.637594; Chen LZ, 2018, ONCOL LETT, V16, P6966, DOI 10.3892/ol.2018.9554; Chen SJ, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-02847-6; Deng XL, 2018, CELL RES, V28, P507, DOI 10.1038/s41422-018-0034-6; Edens BM, 2019, CELL REP, V28, P845, DOI 10.1016/j.celrep.2019.06.072; Ferretti C, 2007, HUM REPROD UPDATE, V13, P121, DOI 10.1093/humupd/dml048; Fondjo LA, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2623-x; Fu Y, 2020, J BIOL REG HOMEOS AG, V34, P1505, DOI 10.23812/20-325-L; Fukusumi Y, 2008, DEV DYNAM, V237, P618, DOI 10.1002/dvdy.21444; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Han X, 2020, CANCER CONTROL, V27, DOI 10.1177/1073274820960460; Hansen TVO, 2004, MOL CELL BIOL, V24, P4448, DOI 10.1128/MCB.24.10.4448-4464.2004; Hong K, 2018, ONCOL LETT, V16, P5519, DOI 10.3892/ol.2018.9395; Horiuchi K, 2006, P NATL ACAD SCI USA, V103, P17278, DOI 10.1073/pnas.0608357103; Huang HL, 2018, NAT CELL BIOL, V20, P285, DOI 10.1038/s41556-018-0045-z; Imam H, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.584283; Imanishi M, 2017, CHEM COMMUN, V53, P12930, DOI 10.1039/c7cc07699a; Jo HJ, 2013, J GASTROENTEROL, V48, P1271, DOI 10.1007/s00535-013-0748-7; Kobayashi M, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00116-18; Kurahashi T, 2010, J CELL BIOCHEM, V109, P49, DOI 10.1002/jcb.22377; Li BQ, 2019, CANCER LETT, V451, P48, DOI 10.1016/j.canlet.2019.02.043; Li DD, 2015, MOL CELL ENDOCRINOL, V413, P13, DOI 10.1016/j.mce.2015.05.038; Li T, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1038-7; Li YY, 2020, LIFE SCI, V247, DOI 10.1016/j.lfs.2020.117441; Lisonkova S, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.08.019; Liu JD, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108120; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Liu SY, 2020, J CELL MOL MED, V24, P2070, DOI 10.1111/jcmm.14847; Liu ZX, 2018, FRONT BIOENG BIOTECH, V6, DOI 10.3389/fbioe.2018.00089; Ma Z, 2020, CELL BIOL INT, V44, P2524, DOI 10.1002/cbin.11459; Paris J, 2019, CELL STEM CELL, V25, P137, DOI 10.1016/j.stem.2019.03.021; Price AM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19787-6; Redman Cwg, 2014, Pregnancy Hypertens, V4, P246, DOI 10.1016/j.preghy.2014.04.020; Ries RJ, 2019, NATURE, V571, P424, DOI 10.1038/s41586-019-1374-1; Roundtree IA, 2017, ELIFE, V6, DOI 10.7554/eLife.31311; Scholler E, 2018, RNA, V24, P499, DOI 10.1261/rna.064063.117; Shulman Z, 2020, NAT IMMUNOL, V21, P501, DOI 10.1038/s41590-020-0650-4; SOULA C, 1990, International Journal of Developmental Biology, V34, P351; Soundararajan Rama, 2004, Reprod Biol Endocrinol, V2, P15, DOI 10.1186/1477-7827-2-15; Tang C, 2018, P NATL ACAD SCI USA, V115, pE325, DOI 10.1073/pnas.1717794115; Tang JY, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0706-6; Tang YJ, 2021, NUCLEIC ACIDS RES, V49, pD134, DOI 10.1093/nar/gkaa692; Wang J, 2020, PEERJ, V8, DOI 10.7717/peerj.9880; Wang J, 2020, J OVARIAN RES, V13, DOI 10.1186/s13048-020-00710-y; Wang W, 2021, J HEALTHC ENG, V2021, DOI 10.1155/2021/9371953; Wen J, 2018, MOL CELL, V69, P1028, DOI 10.1016/j.molcel.2018.02.015; Weng L, 2020, BMC PULM MED, V20, DOI 10.1186/s12890-020-01240-5; Xiang Y, 2017, NATURE, V543, P573, DOI 10.1038/nature21671; Xiao W, 2016, MOL CELL, V61, P507, DOI 10.1016/j.molcel.2016.01.012; Yu HL, 2019, ONCOTARGETS THER, V12, P6191, DOI 10.2147/OTT.S205730; Zaccara S, 2019, NAT REV MOL CELL BIO, V20, P608, DOI 10.1038/s41580-019-0168-5; Zhang F, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008120; Zhang L, 2021, THERANOSTICS, V11, P1100, DOI 10.7150/thno.49345; Zhang WH, 2022, CELL REP, V38, DOI 10.1016/j.celrep.2022.110570; Zhang Z, 2018, INT J MOL MED, V42, P1508, DOI 10.3892/ijmm.2018.3701; Zhong SL, 2008, PLANT CELL, V20, P1278, DOI 10.1105/tpc.108.058883; Zhou Y, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw104	60	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22617	10.1096/fj.202200700RR	http://dx.doi.org/10.1096/fj.202200700RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6K1EQ	36412513				2022-12-26	WOS:000887255100001
J	Nishad, R; Mukhi, D; Kethavath, S; Raviraj, S; Paturi, ASV; Motrapu, M; Kurukuti, S; Pasupulati, AK				Nishad, Rajkishor; Mukhi, Dhanunjay; Kethavath, Srinivas; Raviraj, Sumathi; Paturi, Atreya S. V.; Motrapu, Manga; Kurukuti, Sreenivasulu; Pasupulati, Anil Kumar			Podocyte derived TNF-alpha mediates monocyte differentiation and contributes to glomerular injury	FASEB JOURNAL			English	Article						diabetic kidney disease; growth hormone; macrophages; podocytes; TNF-alpha	NECROSIS-FACTOR-ALPHA; GROWTH-HORMONE; DIABETIC-NEPHROPATHY; CHEMOATTRACTANT PROTEIN-1; MACROPHAGES; PATHOGENESIS; METABOLISM; EXPRESSION; PROLIFERATION; EXCRETION	Diabetes shortens the life expectancy by more than a decade, and the excess mortality in diabetes is correlated with the incidence of kidney disease. Diabetic kidney disease (DKD) is the leading cause of end-stage kidney disease. Macrophage accumulation predicts the severity of kidney injury in human biopsies and experimental models of DKD. However, the mechanism underlying macrophage recruitment in diabetes glomeruli is unclear. Elevated plasma growth hormone (GH) levels in type I diabetes and acromegalic individuals impaired glomerular biology. In this study, we examined whether GH-stimulated podocytes contribute to macrophage accumulation. RNA-seq analysis revealed elevated TNF-alpha signaling in GH-treated human podocytes. Conditioned media from GH-treated podocytes (GH-CM) induced differentiation of monocytes to macrophages. On the other hand, neutralization of GH-CM with the TNF-alpha antibody diminished GH-CM's action on monocytes. The treatment of mice with GH resulted in increased macrophage recruitment, podocyte injury, and proteinuria. Furthermore, we noticed the activation of TNF-alpha signaling, macrophage accumulation, and fibrosis in DKD patients' kidney biopsies. Our findings suggest that podocytes could secrete TNF-alpha and contribute to macrophage migration, resulting in DKD-related renal inflammation. Inhibition of either GH action or TNF-alpha expression in podocytes could be a novel therapeutic approach for DKD treatment.	[Nishad, Rajkishor; Mukhi, Dhanunjay; Raviraj, Sumathi; Paturi, Atreya S. V.; Motrapu, Manga; Pasupulati, Anil Kumar] Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad, India; [Kethavath, Srinivas; Kurukuti, Sreenivasulu] Univ Hyderabad, Sch Life Sci, Dept Anim Biol, Hyderabad, India; [Nishad, Rajkishor; Pasupulati, Anil Kumar] Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500046, India	University of Hyderabad; University of Hyderabad; University of Hyderabad	Nishad, R; Pasupulati, AK (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500046, India.	biochemistry1520@gmail.com; pasupulati.anilkumar@gmail.com		Atreya Sai, Venkata/0000-0003-0170-9284	MOHFW | Department of Health Research, India (DHR) [12020/02/2019 HR]; University of Hyderabad [IoE/RC1--20-21]	MOHFW | Department of Health Research, India (DHR); University of Hyderabad(University of Hyderabad)	MOHFW | Department of Health Research, India (DHR), Grant/Award Number: 12020/02/2019 HR; University of Hyderabad, Grant/Award Number: IoE/RC1--20-21	Awad AS, 2015, KIDNEY INT, V88, P722, DOI 10.1038/ki.2015.162; Bellush LL, 2000, ENDOCRINOLOGY, V141, P163, DOI 10.1210/en.141.1.163; Blutke A, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12709; Campbell JJ, 1996, J CELL BIOL, V134, P255, DOI 10.1083/jcb.134.1.255; Chen Y, 2020, KIDNEY DIS-BASEL, V6, P215, DOI 10.1159/000506634; Chow F, 2004, KIDNEY INT, V65, P116, DOI 10.1111/j.1523-1755.2004.00367.x; Chung CH, 2015, NEPHRON EXTRA, V5, P1, DOI 10.1159/000369576; DiPetrillo K, 2003, AM J PHYSIOL-RENAL, V284, pF113, DOI 10.1152/ajprenal.00026.2002; Doi SQ, 2000, J AM SOC NEPHROL, V11, P1419, DOI 10.1681/ASN.V1181419; DOI T, 1988, AM J PATHOL, V131, P398; Duffield JS, 2010, SEMIN NEPHROL, V30, P234, DOI 10.1016/j.semnephrol.2010.03.003; Duran-Salgado MB, 2014, WORLD J DIABETES, V5, P393, DOI 10.4239/wjd.v5.i3.393; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Guo YF, 2017, ONCOTARGET, V8, P53276, DOI 10.18632/oncotarget.18394; Haffner D, 2021, PEDIATR NEPHROL, V36, P2511, DOI 10.1007/s00467-021-05097-6; Hill GS, 2001, KIDNEY INT, V60, P1893, DOI 10.1046/j.1523-1755.2001.00017.x; Kim SH, 2017, ANN PEDIATR ENDOCRIN, V22, P145, DOI 10.6065/apem.2017.22.3.145; Klessens CQF, 2017, NEPHROL DIAL TRANSPL, V32, P1322, DOI 10.1093/ndt/gfw260; Koike N, 2007, LIFE SCI, V80, P1721, DOI 10.1016/j.lfs.2007.02.001; Kumar PA, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00151; Kumar PA, 2011, CURR DIABETES REV, V7, P50, DOI 10.2174/157339911794273900; Kumar PA, 2010, J BIOL CHEM, V285, P31148, DOI 10.1074/jbc.M110.132332; Liu HY, 2018, ONCOTARGET, V9, P2887, DOI 10.18632/oncotarget.20812; Mensah-Brown EPK, 2005, CYTOKINE, V31, P180, DOI 10.1016/j.cyto.2005.04.006; Moller N, 2009, ENDOCR REV, V30, P152, DOI 10.1210/er.2008-0027; Morii T, 2003, J DIABETES COMPLICAT, V17, P11, DOI 10.1016/S1056-8727(02)00176-9; Moriwaki Y, 2007, ACTA DIABETOL, V44, P215, DOI 10.1007/s00592-007-0007-6; Mukhi D, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00102; Murakami A, 2010, NEPHROL DIAL TRANSPL, V25, P3884, DOI 10.1093/ndt/gfq323; Navarro JF, 2006, NEPHROL DIAL TRANSPL, V21, P3428, DOI 10.1093/ndt/gfl469; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Nguyen D, 2006, NEPHROLOGY, V11, P226, DOI 10.1111/j.1440-1797.2006.00576.x; Niewczas MA, 2019, NAT MED, V25, P805, DOI 10.1038/s41591-019-0415-5; Nishad R, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03643-6; Nishad R, 2019, J BIOL CHEM, V294, P16109, DOI 10.1074/jbc.RA119.008966; Pasupulati AK, 2019, CURR OPIN NEPHROL HY, V28, P10, DOI 10.1097/MNH.0000000000000468; Pilmore HL, 2000, TRANSPLANTATION, V69, P2658, DOI 10.1097/00007890-200006270-00028; Reddy GR, 2007, ENDOCRINOLOGY, V148, P2045, DOI 10.1210/en.2006-1285; Rovin BH, 1996, AM J KIDNEY DIS, V27, P640, DOI 10.1016/S0272-6386(96)90097-9; Segev Y, 1999, J AM SOC NEPHROL, V10, P2374; Tesch GH, 2010, SEMIN NEPHROL, V30, P290, DOI 10.1016/j.semnephrol.2010.03.007; Thomas MC, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.18; Vemula MH, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01347; Vijayakumar Archana, 2011, Front Endocrinol (Lausanne), V2, P32, DOI 10.3389/fendo.2011.00032; Wang ZH, 2007, ENDOCRINOLOGY, V148, P2845, DOI 10.1210/en.2006-1313; Whitney JL, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-12; Wojciak-Stothard B, 1998, J CELL PHYSIOL, V176, P150, DOI 10.1002/(SICI)1097-4652(199807)176:1<150::AID-JCP17>3.0.CO;2-B; Yang NS, 1998, KIDNEY INT, V54, P143, DOI 10.1046/j.1523-1755.1998.00978.x; YOUNG BA, 1995, KIDNEY INT, V48, P439, DOI 10.1038/ki.1995.312; Zhang XL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103067	50	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22622	10.1096/fj.202200923R	http://dx.doi.org/10.1096/fj.202200923R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6P1IR	36421039				2022-12-26	WOS:000890688400001
J	Sabarwal, A; van Rooyen, JC; Caburet, J; Avgenikos, M; Dheeraj, A; Ali, M; Mishra, D; de Meester, JSB; Stander, S; van Otterlo, WAL; Kaschula, CH; Singh, RP				Sabarwal, Akash; van Rooyen, Jaco C.; Caburet, Jeremy; Avgenikos, Moscos; Dheeraj, Arpit; Ali, Mansoor; Mishra, Deepali; de Meester, Josephine S. B.; Stander, Saskia; van Otterlo, Willem A. L.; Kaschula, Catherine H.; Singh, Rana P.			A novel 4 '-brominated derivative of fisetin induces cell cycle arrest and apoptosis and inhibits EGFR/ERK1/2/STAT3 pathways in non-small-cell lung cancer without any adverse effects in mice	FASEB JOURNAL			English	Article						brominated derivative; fisetin; flavonol; hepatotoxicity; lung cancer; synthetic analogues	DIETARY FLAVONOID FISETIN; BIOLOGICAL EVALUATION; ANTICANCER ACTIVITY; ACTIVATION; PROLIFERATION; REQUIREMENTS; PURIFICATION; VIABILITY; REDUCTASE; PI3K/AKT	The therapeutic toxicity and resistance to currently available treatment options are major clinical challenges for the management of lung cancer. As a novel strategy, we synthesized analogues of a known flavonol, fisetin, which has shown anti-tumorigenic potential against cancer in cell culture with no adverse effects in animal models. We studied the synthetic analogues of fisetin for their anti-cancer potential against lung cancer cells, toxicity in mice and efficacy in a xenograft model. Brominated fisetin analogues were screened for their effects on the viability of A549 and H1299 lung cancer cells, and three analogues (3a, 3b, 3c), showed improved activity compared to fisetin. These analogues were more effective in restricting lung cancer cell proliferation, inducing G(2)M phase cell cycle arrest and apoptosis. The fisetin analogues also downregulated EGFR/ERK1/2/STAT3 pathways. Fisetin analogue-induced apoptosis was accompanied by a higher Bax to Bcl-2 expression ratio. Based on the in vitro studies, the most effective fisetin analogue 3b was evaluated for in vivo toxicity, wherein it did not show any hepatotoxicity or adverse health effects in mice. Furthermore, analogue 3b showed greater antitumor efficacy (p < .001) as compared to its parent compound fisetin in a human lung cancer cell xenograft study in athymic mice. Together, our data suggest that the novel fisetin analogue 3b is more effective in restricting lung cancer cell growth, both in vitro as well as in vivo, without any apparent toxicity, supporting its further development as a novel anti-lung cancer agent.	[Sabarwal, Akash; Dheeraj, Arpit; Ali, Mansoor; Mishra, Deepali; Singh, Rana P.] Jawaharlal Nehru Univ, Sch Life Sci, Canc Biol Lab, New Delhi, India; [van Rooyen, Jaco C.; Caburet, Jeremy; Avgenikos, Moscos; de Meester, Josephine S. B.; Stander, Saskia; van Otterlo, Willem A. L.; Kaschula, Catherine H.] Stellenbosch Univ, Dept Chem & Polymer Sci, Matieland, South Africa; [Caburet, Jeremy] Univ Clermont Auvergne, Sigma Clermont, Aubiere, France; [de Meester, Josephine S. B.] Catholic Univ Louvain, Fac Sci, Louvain la Neuve, Belgium; [Singh, Rana P.] Jawaharlal Nehru Univ, Special Ctr Syst Med, New Delhi, India; [Sabarwal, Akash] Boston Childrens Hosp, Div Nephrol, Boston, MA USA; [Sabarwal, Akash] Harvard Med Sch, Boston, MA USA; [Dheeraj, Arpit] Oregon Hlth & Sci Univ, Arpit Dheeraj, Portland, OR USA; [Kaschula, Catherine H.] Stellenbosch Univ, Dept Chem & Polymer Sci, ZA-7800 Matieland, South Africa; [Singh, Rana P.] Jawaharlal Nehru Univ, Sch Life Sci, Canc Biol Lab, New Delhi 11067, India	Jawaharlal Nehru University, New Delhi; Stellenbosch University; Universite Clermont Auvergne (UCA); Universite Catholique Louvain; Jawaharlal Nehru University, New Delhi; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Oregon Health & Science University; Stellenbosch University; Jawaharlal Nehru University, New Delhi	Kaschula, CH (corresponding author), Stellenbosch Univ, Dept Chem & Polymer Sci, ZA-7800 Matieland, South Africa.; Singh, RP (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Canc Biol Lab, New Delhi 11067, India.	kaschula@sun.ac.za; rana_singh@mail.jnu.ac.in		Sabarwal, Akash/0000-0003-1760-4903; van Otterlo, Willem/0000-0002-3300-6463				Adhami VM, 2012, BIOCHEM PHARMACOL, V84, P1277, DOI 10.1016/j.bcp.2012.07.012; Ahn-Jarvis JH, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8070202; Azad Adiba, 2018, J Clin Gastroenterol Hepatol, V2, DOI 10.21767/2575-7733.1000047; Bahirwani R, 2014, SEMIN LIVER DIS, V34, P162, DOI 10.1055/s-0034-1375957; Beutler JA, 1998, J MED CHEM, V41, P2333, DOI 10.1021/jm970842h; Bian CN, 2018, ONCOL LETT, V15, P9655, DOI 10.3892/ol.2018.8587; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Britton RG, 2012, EUR J MED CHEM, V54, P952, DOI 10.1016/j.ejmech.2012.06.031; Burmistrova O, 2014, EUR J MED CHEM, V84, P30, DOI 10.1016/j.ejmech.2014.07.010; Chang H, 2008, ARCH PHARM RES, V31, P1137, DOI 10.1007/s12272-001-1280-8; Chen CC, 2010, ONCOL REP, V23, P639, DOI 10.3892/or_00000679; Cui Y, 2008, CANCER-AM CANCER SOC, V112, P2241, DOI 10.1002/cncr.23398; Daskiewicz JB, 2005, J MED CHEM, V48, P2790, DOI 10.1021/jm040770b; Dias TA, 2013, EUR J MED CHEM, V65, P500, DOI 10.1016/j.ejmech.2013.04.064; Forbes AM, 2014, INT J ONCOL, V45, P831, DOI 10.3892/ijo.2014.2452; Gutierrez-Venegas G, 2014, J ASIAN NAT PROD RES, V16, P1009, DOI 10.1080/10286020.2014.932351; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hanahan D, 2022, CANCER DISCOV, V12, P31, DOI 10.1158/2159-8290.CD-21-1059; Khan N, 2008, CARCINOGENESIS, V29, P1049, DOI 10.1093/carcin/bgn078; Khan N, 2013, ANTIOXID REDOX SIGN, V19, P151, DOI 10.1089/ars.2012.4901; Kumar K, 2019, MITOCHONDRION, V48, P1, DOI 10.1016/j.mito.2018.06.003; Lall RK, 2016, MOL NUTR FOOD RES, V60, P1396, DOI 10.1002/mnfr.201600025; Le Marchand L, 2000, JNCI-J NATL CANCER I, V92, P154, DOI 10.1093/jnci/92.2.154; Li J, 2011, BASIC CLIN PHARMACOL, V108, P84, DOI 10.1111/j.1742-7843.2010.00613.x; Liang Y, 2021, FOOD FUNCT, V12, P10667, DOI [10.1039/d1fo02002a, 10.1039/D1FO02002A]; Lin MT, 2016, TUMOR BIOL, V37, P6987, DOI 10.1007/s13277-015-4526-4; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; MIHARA K, 1975, J BIOCHEM-TOKYO, V78, P1057, DOI 10.1093/oxfordjournals.jbchem.a130983; Min KJ, 2017, MOLECULES, V22, DOI 10.3390/molecules22081285; OMURA T, 1970, J BIOCHEM-TOKYO, V67, P249, DOI 10.1093/oxfordjournals.jbchem.a129248; Pouget C, 2001, BIOORG MED CHEM LETT, V11, P3095, DOI 10.1016/S0960-894X(01)00617-5; Punia R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182870; Rodriguez J, 2002, MELANOMA RES, V12, P99, DOI 10.1097/00008390-200204000-00001; Rubio S, 2006, EUR J PHARMACOL, V548, P9, DOI 10.1016/j.ejphar.2006.07.020; Sabarwal A, 2022, CARCINOGENESIS, V43, P360, DOI 10.1093/carcin/bgab126; Sabarwal A, 2020, CANCERS, V12, DOI 10.3390/cancers12071782; Sabarwal A, 2017, MOL CARCINOGEN, V56, P499, DOI 10.1002/mc.22512; Shi ZH, 2014, BIOORG MED CHEM LETT, V24, P4424, DOI 10.1016/j.bmcl.2014.08.006; Tabasum S, 2019, CHEM-BIOL INTERACT, V303, P14, DOI 10.1016/j.cbi.2019.02.020; Tang NP, 2009, JPN J CLIN ONCOL, V39, P352, DOI 10.1093/jjco/hyp028; Tang YM, 2022, PHYTOMEDICINE, V101, DOI 10.1016/j.phymed.2022.154109; Tripathi SC, 2017, CANCER RES, V77, P4414, DOI 10.1158/0008-5472.CAN-16-2874; VARSHNEY R, 1990, INT J RADIAT BIOL, V58, P733, DOI 10.1080/09553009014552121; Walle T, 2007, SEMIN CANCER BIOL, V17, P354, DOI 10.1016/j.semcancer.2007.05.002; Wang JJ, 2018, EXP THER MED, V15, P2667, DOI 10.3892/etm.2017.5666; Ye CY, 2017, ONCOTARGET, V8, P2224, DOI 10.18632/oncotarget.13653; Zhang L, 2016, AM J TRANSL RES, V8, P4857; Zhao JQ, 2021, FOOD CHEM TOXICOL, V155, DOI 10.1016/j.fct.2021.112411	48	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22654	10.1096/fj.202200669RR	http://dx.doi.org/10.1096/fj.202200669RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6N0IY	36421014				2022-12-26	WOS:000889246400001
J	He, XG; Chen, JG; Zhou, JM; Mao, AR; Xu, WQ; Zhu, HX; Pan, Q; Zhao, YM; Zhang, N; Wang, LR; Wang, M; Liu, ZY; Zhu, WP; Wang, L				He, Xigan; Chen, Jinggui; Zhou, Jiamin; Mao, Anrong; Xu, Weiqi; Zhu, Hongxu; Pan, Qi; Zhao, Yiming; Zhang, Ning; Wang, Longrong; Wang, Miao; Liu, Zeyang; Zhu, Weiping; Wang, Lu			LncRNA-EWSAT1 promotes hepatocellular carcinoma metastasis via activation of the Src-YAP signaling axis	FASEB JOURNAL			English	Article						EWSAT1; hepatocellular carcinoma; Hippo-YAP; metastasis; Src	LONG NONCODING RNAS; HIPPO PATHWAY; EWSAT1; EXPRESSION; SURVIVAL	Regardless of the improvements in diagnostic and therapeutic methods, the clinical outcomes of hepatocellular carcinoma (HCC) patients remain poor. Although accumulating evidence indicates that lncRNAs (long noncoding RNAs) are essential within the control of tumorigenesis and the metastasis of cancer, the underlying mechanisms remain largely unknown. This work explored the pattern of expression and functional significance of a newly found lncRNA, Ewing sarcoma-associated transcript 1 (EWSAT1), in HCC metastasis. The results indicated that EWSAT1 was upregulated significantly in HCC relative to that in normal tissues and was correlated with an aggressive phenotype and low patient survival. Functional experiments demonstrated that EWSAT1 could promote proliferation and HCC cell metastasis both in vitro and in vivo. Mechanistically, EWSAT1 binds directly to Yes-associated protein (YAP), promotes Sarcoma gene (Src)-induced phosphorylation of YAP, facilitates nuclear translocation of YAP, and consequently, activates the transcription of Hippo-YAP signaling target genes involved in cancer evolution. This study found that EWSAT1 plays a crucial role in HCC metastasis and that it has the potential to be a prognosis biomarker and a target for therapeutics.	[He, Xigan; Zhou, Jiamin; Mao, Anrong; Xu, Weiqi; Zhu, Hongxu; Pan, Qi; Zhao, Yiming; Zhang, Ning; Wang, Longrong; Wang, Miao; Zhu, Weiping; Wang, Lu] Fudan Univ, Fudan Univ Shanghai Canc Ctr, Shanghai Med Coll, Dept Hepat Surg, Shanghai, Peoples R China; [Chen, Jinggui] Fudan Univ, Fudan Univ Shanghai Canc Ctr, Shanghai Med Coll, Dept Gastr Surg, Shanghai, Peoples R China; [Liu, Zeyang] Shandong Univ, Dept Gen Surg, Qilu Hosp, Jinan, Peoples R China; [Zhu, Weiping; Wang, Lu] Fudan Univ, Fudan Univ Shanghai Canc Ctr, Shanghai Med Coll, Dept Hepat Surg, Shanghai 200032, Peoples R China	Fudan University; Fudan University; Shandong University; Fudan University	Zhu, WP; Wang, L (corresponding author), Fudan Univ, Fudan Univ Shanghai Canc Ctr, Shanghai Med Coll, Dept Hepat Surg, Shanghai 200032, Peoples R China.	wpzhush@hotmail.com; wangluzl@fudan.edu.cn			National Key project of CHina [2017ZX10203204-007-004]; National Natural Science Foundation of China (NSFC) [81874182, 81874056, 81372314, 81272393]; Public Health Bureau Foundation of Shanghai [201840019]; Research Talent Foundation of Fudan University Shanghai Cancer Center [YJRC1604]; Young Eagle Project of Shanghai Anticancer Association [SACA-CY20A05]	National Key project of CHina; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Public Health Bureau Foundation of Shanghai; Research Talent Foundation of Fudan University Shanghai Cancer Center; Young Eagle Project of Shanghai Anticancer Association	National Key project of CHina, Grant/Award Number: 2017ZX10203204-007-004; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81874182, 81874056, 81372314 and 81272393; Public Health Bureau Foundation of Shanghai, Grant/Award Number: 201840019; Research Talent Foundation of Fudan University Shanghai Cancer Center, Grant/Award Number: YJRC1604; Young Eagle Project of Shanghai Anticancer Association, Grant/Award Number: SACA-CY20A05	Cheetham SW, 2013, BRIT J CANCER, V108, P2419, DOI 10.1038/bjc.2013.233; Chen XJ, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10010066; Coleman MP, 2014, LANCET, V383, P564, DOI 10.1016/S0140-6736(13)62225-4; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Faranda T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45604-2; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Forner A, 2018, LANCET, V391, P1301, DOI 10.1016/S0140-6736(18)30010-2; Fu X, 2017, AM J TRANSL RES, V9, P4094; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Howarth MM, 2014, J CLIN INVEST, V124, P5275, DOI 10.1172/JCI72124; Hsu PC, 2020, CANCERS, V12, DOI 10.3390/cancers12061361; Huang RY, 2015, BIOCHEM BIOPH RES CO, V467, P602, DOI 10.1016/j.bbrc.2015.08.119; Huang Z, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01188-4; Manganelli M, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9070813; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Mohammadi S, 2020, BIOFACTORS, V46, P514, DOI 10.1002/biof.1634; Peng WX, 2017, ONCOGENE, V36, P5661, DOI 10.1038/onc.2017.184; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Shen DW, 2021, J CELL MOL MED, V25, P716, DOI 10.1111/jcmm.16121; Song P, 2016, AGING-US, V8, P2948, DOI 10.18632/aging.101103; Sun LS, 2016, DNA CELL BIOL, V35, P812, DOI 10.1089/dna.2016.3467; Taniguchi K, 2015, NATURE, V519, P57, DOI 10.1038/nature14228; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tu C, 2020, CELL PROLIFERAT, V53, DOI 10.1111/cpr.12887; Yang H, 2020, ONCOL LETT, V20, P1846, DOI 10.3892/ol.2020.11716; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Zhang GY, 2017, EUR REV MED PHARMACO, V21, P5337, DOI 10.26355/eurrev_201712_13918; Zhang R, 2018, EUR REV MED PHARMACO, V22, P6801, DOI 10.26355/eurrev_201810_16146; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhou QY, 2020, MOL CELL BIOCHEM, V471, P177, DOI 10.1007/s11010-020-03778-8	31	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2022	36	12							e22663	10.1096/fj.202200825R	http://dx.doi.org/10.1096/fj.202200825R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	6O0IQ	36421017				2022-12-26	WOS:000889930700001
